Avanos Medical (AVNS) Financial Statements & Analysis

Avanos Medical (AVNS) Income Statement

Avanos Medical reported revenue of $701.20M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 1.9% from $687.80M a year earlier. Avanos Medical posted a net loss of $67.90M, compared with net income of $392.10M a year earlier. Gross margin was 49.8% and operating margin -8.8%. In the most recent quarter, Q1 fiscal 2026 (ended Mar 31, 2026), revenue was $182.20M, up 8.8% from the same quarter a year earlier.

Avanos Medical Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Avanos Medical, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	701.20	687.80	673.30	684.10	587.00	714.80	697.60	652.30	611.60
Cost of Revenue	352.20	306.50	293.60	289.90	287.80	343.90	295.40	261.40	274.70
Gross Profit	349.00	381.30	379.70	394.20	299.20	370.90	402.20	390.90	336.90
Operating Expenses
Research & Development	23.10	12.40	27.20	30.60	30.60	34.90	37.70	41.80	38.20
Selling, General & Administrative	218.30	330.00	335.00	323.10	285.30	327.20	369.90	314.20	314.70
Operating Expenses	410.60	785.30	375.50	352.30	338.20	366.50	407.60	356.00	352.90
Operating Income	-61.60	-396.20	4.20	41.90	-39.00	4.40	-5.40	34.90	-16.00
Other Income/Expense
Interest Income	3.20	5.10	2.90	1.20	0.20	1.20	6.70	7.80	2.50
Interest Expense	4.00	-12.20	15.00	10.00	3.30	-15.60	15.00	26.40	31.60
Other Income/Expense	-4.60	-7.10	-12.10	-15.20	-25.40	-131.40	-58.60	-53.00	-56.20
Income
Income Before Tax	-66.20	-403.30	-7.90	26.70	-42.10	-62.90	-64.00	-18.10	-72.20
Income Tax Expense	1.70	-17.00	2.00	5.20	-11.20	-33.90	-18.10	-9.60	-40.10
Net Income	-67.90	392.10	-61.80	50.50	6.30	-29.00	-45.90	57.50	79.30
Net Income - Continuous Operations	-67.90	-392.10	-9.90	50.50	-30.90	-27.20	-45.90	57.50	79.30
Net Income - Discontinued Operations	-	-5.80	-51.90	29.00	37.20	-	-	-	-
EBITDA	-33.20	81.40	53.20	77.80	-0.50	47.30	-12.10	37.00	-0.60
EBIT	15.50	35.90	7.10	36.70	-38.80	4.40	-	-	-
Depreciation & Amortization	29.00	45.50	46.10	41.10	38.30	42.90	36.90	33.50	40.00
Earnings Per Share
Basic EPS	-1.00	-9.00	-1.00	1.00	-	-1.00	-1.00	1.00	2.00
Diluted EPS	-1.00	-9.00	-1.00	1.00	-	-1.00	-1.00	1.00	2.00
Basic Shares Outstanding	46.40	46.00	46.60	46.90	48.10	47.80	47.60	47.20	46.52
Diluted Shares Outstanding	46.40	46.00	46.60	47.30	48.60	47.80	47.60	47.20	46.80

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Frequently Asked Questions About Avanos Medical Financial Statements

What was Avanos Medical's revenue in fiscal 2025?

Avanos Medical reported revenue of $701.20M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 1.9% from $687.80M a year earlier.

Is Avanos Medical profitable?

No. Avanos Medical reported a net loss of $67.90M in fiscal 2025. In fiscal 2024 it earned $392.10M.

What is Avanos Medical's operating margin?

Avanos Medical's operating income was −$61.60M on revenue of $701.20M in fiscal 2025, an operating margin of -8.8%, compared with -57.6% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition